Literature DB >> 10953288

How can tumor cells escape intercellular induction of apoptosis?

I Engelmann1, G Bauer.   

Abstract

A novel concept for the control of oncogenesis has been established for fibroblasts. Transformed fibroblasts are subject to intercellular induction of apoptosis by TGF-beta or FGF-triggered nontransformed neighboring cells. If this control system acts in vivo as efficiently as it does in vitro, tumor formation should require the establishment of resistance mechanisms directed against intercellular induction of apoptosis. In line with this hypothesis, ex vivo tumor cells have been recently shown to be resistant to intercellular induction of apoptosis, whereas cells transformed in vitro and not passaged in an organism were regularly sensitive. Based on the knowledge of signaling between transformed and nontransformed cells during intercellular induction of apoptosis, several possible mechanisms for resistance of tumor cells are summarized in this paper.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953288

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

Review 1.  The functions of cytokines and their uses in toxicology.

Authors:  J R Foster
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

Review 2.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

3.  Power spectrum scale invariance quantifies limbic dysregulation in trait anxious adults using fMRI: adapting methods optimized for characterizing autonomic dysregulation to neural dynamic time series.

Authors:  Denis Tolkunov; Denis Rubin; Lr Mujica-Parodi
Journal:  Neuroimage       Date:  2009-12-16       Impact factor: 6.556

Review 4.  It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment.

Authors:  M H Barcellos-Hoff
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

5.  Design and evaluation of new chemotherapeutics of aloe-emodin (AE) against the deadly cancer disease: an in silico study.

Authors:  Chaitanya Mulakayala; Babajan Banaganapalli; Naveen Mulakayala; Madhusudana Pulaganti; Anuradha C M; Suresh Kumar Chitta
Journal:  J Chem Biol       Date:  2013-05-23

Review 6.  Cancer as an emergent phenomenon in systems radiation biology.

Authors:  Mary Helen Barcellos-Hoff
Journal:  Radiat Environ Biophys       Date:  2007-11-20       Impact factor: 1.925

7.  Low-dose radiation-induced protective process and implications for risk assessment, cancer prevention, and cancer therapy.

Authors:  B R Scott
Journal:  Dose Response       Date:  2007-06-04       Impact factor: 2.658

8.  Low-dose radiation and genotoxic chemicals can protect against stochastic biological effects.

Authors:  Bobby R Scott; Dale M Walker; Vernon E Walker
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-07

9.  Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin.

Authors:  M Hunter Joyce; Carolyne Lu; Emily R James; Rachel Hegab; Shane C Allen; Laura J Suggs; Amy Brock
Journal:  Front Oncol       Date:  2018-09-05       Impact factor: 6.244

10.  Cytochrome C as a potential clinical marker for diagnosis and treatment of glioma.

Authors:  Rashmi Rana; Rohit Singh Huirem; Ravi Kant; Kirti Chauhan; Swati Sharma; M H Yashavarddhan; Satnam Singh Chhabra; Rajesh Acharya; Samir Kumar Kalra; Anshul Gupta; Sunila Jain; Nirmal Kumar Ganguly
Journal:  Front Oncol       Date:  2022-09-13       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.